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a b s t r a c t
Molecular epidemiologic studies of North American (NA) West Nile virus (WNV; Flaviviridae, Flavivirus)
have documented the displacement of the introduced NY99 genotype with WN02. In addition, these
studies have shown that particular substitutions are under positive selection. One occurs in the C-
terminus of the NS4A coding sequence and results in a valine to methionine substitution at position nine
of the 2K peptide. 2K-V9M confers the ability to overcome superinfection exclusion in vitro. We
hypothesized that WNV strains bearing 2K-V9M have higher ﬁtness than wildtype in Culex quinque-
fasciatus mosquitoes. Although infection rates and viral titers were not signiﬁcantly different, virus
dissemination rates were signiﬁcantly higher with WNV 2K-V9M. As a super-infecting virus, WNV 2K-
V9M was more successful than wildtype, however, in a mixed infection, 2K-V9M was not. These data
support observations that 2K-V9M confers a context-speciﬁc selective advantage in mosquitoes and
provides an in vivo mechanism for its positive selection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
WNV has caused the largest neuroinvasive arbovirus disease
outbreaks recorded in North America (NA, reviewed in Petersen et
al., 2013). Viral transmission is maintained mainly by passerine
bird-Culex mosquito ampliﬁcation (Jerzak et al., 2005; Kilpatrick et
al., 2006; Komar et al., 2003; Nash et al., 2001). The WNV strain
ﬁrst established in NA, NY99, has been supplanted by a second
strain, WN02. However rare genome variants continue to circulate
regionally (Armstrong et al., 2011; Davis et al., 2005; Ebel et al.,
2004; Herring et al., 2007). Ongoing molecular epidemiologic
studies documenting the continuing emergence of local variants
in nature have provided the opportunity to study positively
selected virus variants that may alter transmission dynamics.
A number of naturally occurring positively selected WNV
genome variants have been identiﬁed. For example, a positively
selected mutation in the WNV NS3 protein at T249P was able to
signiﬁcantly increase pathogenicity in American crows (Brault et
al., 2007). Another positively selected mutation in the 2K peptide
confers a change from valine to methionine at amino acid position
9; it has been identiﬁed in multiple natural isolates from mosqui-
toes and American crows (Armstrong et al., 2011; Pesko et al.,
2012). Interestingly, independent studies demonstrated that 2K-
V9M allows WNV to replicate in the presence of ﬂavivirus
inhibitors in mammalian cell culture (Mertens et al., 2010; Zou
et al., 2009a). In an in vitro replicon system it also allowed WNV to
overcome superinfection exclusion (Zou et al., 2009b). An addi-
tional mutation, identiﬁed by serial passage of WNV in vitro,
bearing a single nucleotide substitution in NS4A, K124R, also
allowed the virus to overcome superinfection exclusion (Zou et
al., 2009b). Superinfection exclusion occurs when a cell infected
with one virus strain prevents infection with a second virus strain.
This phenomenon is well described in mosquito cells (Condreay
and Brown, 1986; Karpf et al., 1997), and is thought to, in part,
shape transmission dynamics in regions where infection rates are
extremely high (Pesko and Mores, 2009). With WNV, superinfec-
tion exclusion is most dramatic when the secondary infection is a
closely related ﬂavivirus, less clear with more distantly related
ﬂaviviruses, such as dengue, and undetectable with a nonﬂavivirus
(Zou et al., 2009b). Therefore we hypothesized that the mechan-
ism that underpins the observed positive selection for 2K-V9M
may be an enhanced ability to overcome superinfection exclusion
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in relevant vector species. We used WNV infectious clones bearing
single nucleotide mutations at 2K-V9M or NS4A K124R, as well as
the double mutant 2K-V9M, NS4A K124R to characterize the
impact of these mutants on the vector competence of a major
WNV vector, Cx quinquefasciatus. Genotypes with altered vector
competence compared to wildtype infectious clones were then
assessed for superinfection exclusion in vivo. 2K-V9M conferred a
slight transmission advantage in mosquitoes in isolation, and more
substantially as a superinfecting virus. These results provide an
in vivo mechanistic link between molecular evolutionary and
tissue-culture based studies that have identiﬁed this mutation as
positively selected.
Results
Viral infection phenotypes
Vector competence phenotypes were tested in adult Cx quin-
quefasciatus orally infected with one of three WNV point mutants
(2K-V9M, NS4a K124R or the double mutant) compared to wild-
type (NY99ic). At 7 and 14 days post-infection (dpi), mosquito
carcasses, legs/wings, and salivary expectorants were collected for
estimation of infection, dissemination and transmission rates,
respectively, by plaque titration. There were no signiﬁcant differ-
ences in infection phenotypes at 7dpi (Fig. 1A, Table 1). By 14 dpi,
the 2K-V9M mutant showed a signiﬁcantly higher dissemination
rate than the NS4A K124R mutant or the double mutant (NS4A
K124R, 2K-V9M), compared to NY99ic (Chi-Square¼11.66, p¼
0.0087) (Fig. 1B, Table 1). However, viral titers for bodies remained
higher for NY99ic infections than for all mutants (Kruskal–Wallis
test, p¼0.0002).
Superinfection
To investigate the impact of 2K-V9M on the ability to overcome
superinfection exclusion, viral ﬁtness was assessed following a
dual infection scheme. Mosquitoes were ﬁrst given a primary
peroral infection with a marked WNV reference strain and 5 days
later, a secondary infection was established orally with either
NY99ic wildtype or the 2K-V9M (Fitzpatrick et al., 2010). Midguts
were collected at 7, 14, 21, and 28 days following the second
feeding. At 14 dpi, via polySNP analysis (Fitzpatrick et al., 2010;
Hall and Little, 2007), mosquito midguts secondarily infected with
2K-V9M had a signiﬁcantly higher proportion of the superinfecting
genotype than did those superinfected by wildtype (Fig. 2) (Mann–
Whitney, p value¼0.0194). To assess the ﬁtness of 2K-V9M
compared to wildtype in a dual infection, but without the
requirement for superinfection, mosquitoes were fed on a blood-
meal containing a 56.6%:43.3% mixture of 2K and NY99ref,
respectively. The 2K-V9M genotype did not predominate in any
mosquito tissue collected at 14 dpi (Table 2).
Fig. 1. At 14 dpi, dissemination rates of 2K V9M WNV were signiﬁcantly higher than that of WNV NY99_ic. A. 7dpi. B. 14 dpi. Viral titers for positive samples are shown. In
(A) and (B), Left panel: Infection rate is represented by carcass infections; middle panel: dissemination rate represents infection of leg/wings; right panel: transmission rates
were determined from salivary expectorants. NY99ic viral titers are signiﬁcantly higher than all mutants (Dunn0s multiple comparisons test, alpha¼ 0.05; Kruskal–Wallis
test, p¼0.0002); NS4A(K124R), 2K-V9M, 2K mutant, NY99ic, wildtype, double mutant (NS4A K124R, 2K-V9M). Bars indicate geometric mean and 95% conﬁdence interval.
These data are the compilation of two biological replicates using a total of 50 mosquitoes for each timepoint. Infection rates are shown in Table 1. Plotting and statistical
analyses were performed in GraphPad Prism.
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Discussion
Molecular epidemiologic studies have identiﬁed 2K-V9M as
being a positively selected mutation, and tissue culture studies
have suggested that this mutation confers resistance to superinfec-
tion exclusion. Accordingly, we evaluated whether this mutation
would increase transmission ﬁtness in relevant mosquito vectors.
While the 2K-V9M genotype showed increased dissemination
compared to wildtype at 14 dpi, wildtype maintained higher body
viral titers. Moreover, transmission, indicated by the presence of
virus in salivary expectorants, was not increased in the presence of
the 2K-V9M mutant. Thus, although 2K-V9M increases spread
within the mosquito host, the lack of increased transmission
diminishes the impact of this gain of function mutation.
We next evaluated whether 2K-V9M would impact the ability
of WNV to overcome superinfection exclusion. We found that at 14
dpi, more secondary infection genotypes representing 2K-V9M
were present than those infected with wildtype. We therefore
conclude that 2K-V9M confers resistance to superinfection exclu-
sion in vivo in mosquitoes. In addition, these results would suggest
that 2K-V9M may allow WNV to replicate more efﬁciently in
mosquitoes infected by mosquito-only ﬂaviviruses (Calzolari et
al., 2012; Tyler et al., 2011), although this issue has not been tested
directly.
Finally, in a mixed infection competition experiment where
mosquitoes were exposed to wildtype and 2K-V9M simulta-
neously, the 2K-V9M mutant did not have a competitive advantage
over NY99ic in any tissue tested. Therefore, 2K-V9M does not
possess a selective advantage over wildtype when superinfection
of previously infected mosquitoes is not required. Collectively,
these results point to a highly context-speciﬁc ﬁtness advantage
for 2K-V9M, which supports the observations that it is positively
selected in nature and its lack of ﬁxation in the population.
The WNV 2K peptide is a 23 amino acid transmembrane peptide
at the carboxyterminus of NS4A that spans the endoplasmic reticu-
lum (ER) between NS4A and NS4B; in addition, it serves as a signal
peptide for NS4B. 2K is cleaved from NS4A by the NS2B–NS3 viral
protease and from NS4B by a host signal peptidase (Nall et al., 2004;
Shiryaev et al., 2007). In its mature form as a structural peptide, 2K
may alter the topology of the ER during WNV infection. The 2K
peptide has been described to be present in vivo fused to the
carboxy-terminus of NS4A or the amino-terminus of NS4B
(Mertens et al., 2010). Importantly, a study of WNV in human cell
culture found that, at the light microscope level of resolution,
localization and processing of NS4A-2K and 2K-NS4B remained
unaltered with V9M (Mertens et al., 2010). To assess the possible
implications of the V9M mutation for membrane topology, the
secondary structure of the 2K peptide was assessed upon total
cleavage and in the context of the NS4A-2K or 2K-NS4B conforma-
tions using a structural prediction algorithm (http://harrier.nagaha
ma-i-bio.ac.jp/sosui/sosui_submit.html) (Mitaku et al., 2002). No
signiﬁcant changes to hydrophobicity or overall secondary structure
were found. However, the ﬁrst transmembrane domain of the 2K-
V9M-NS4B helices was altered from a primary helix motif to a
secondary type helix (Suppl. Fig. 1). Primary transmembrane helices
contain amphiphilic helical side chains with high hydrophobicity in
central residues, and secondary helices have been proposed to play a
role in protein active sites (Hirokawa et al., 1998). Another study has
shown that WNV NS4B interacts with NS1, and possibly affects
replication complexes (Youn et al., 2012). Therefore, one hypothesis
Table 1
Mosquito tissue infection rates.
Infection rate Dissemination rate Transmission rate
Carcasses Legs/wings Saliva
Strain NS4A 2K Double WT NS4A 2K Double WT NS4A 2K Double WT
7 DPI % 62 88 76 88 2 4 10 10 2 2 8 4
14 DPI % 90 96 80 88 30 60a 32 42 26b 38 26 32
a 2K-V9M dissemination rate is signiﬁcantly higher than NY99ic, (Chi-Square¼11.66, p value¼0.0087).
b Some saliva samples were positive by cytopathic effects assay but could not be quantitated by plaque assay. WT, wildtype. These data reﬂect the combined results of a
total of 50 mosquitoes for each timepoint over two biological replicates.
Fig. 2. Following superinfection of midguts, 2K-V9M is present at higher propor-
tion than wildtype. Data are a compilation of 2 biological replicates. Median values,
white circles; shape limits are at the 25th and 75th percentiles; black bars (Tukey
whiskers) extend 1.5 times the interquartile range from 25th to 75th percentiles;
shapes are representative of data density estimates. Asterisk indicates statistically
signiﬁcant difference (Mann–Whitney, p value¼0.0194). Plot created with http://
boxplot.tyerslab.com/ (Spitzer et al., 2014). ‘dpi’ indicates day post-infection; N
indicates number of midguts in each group. This data reﬂects two biological
replicates.
Table 2
Mixed infection.
Mixed infectiona 2K V9M 100% REF-100%
Tissue Median %
2K-V9M
genotype
N Std
dev
Median %
2K-V9M
genotype
N Std
dev
Median %
Reference
genotype
N Std
dev
Midguts 34.3 25 32.9 96.0 7 7.9 97.2 7 3.3
Legs/wings 7.0 20 33.0 97.8 6 26.4 97.5 8 1.5
Saliva 44.9 12 35.3 86.3 2 3.4 98.24 2 na
2K V9M genotype does not have a competitive ﬁtness advantage over NY99ref in a
mixed infection. Mosquitoes were fed a mixed virus of 56.6%: 43.3% (2K V9M:
NY99ref). Percent viral genotypes were determined by polySNP.
a Mixed virus was 57%:43% (Mutant: Reference). N indicates the number of
mosquitoes per group. (Std dev), standard deviation.
C.L. Campbell et al. / Virology 464-465 (2014) 228–232230
for the gain-of-function of 2K-V9M is that it alters function of 2K-
NS4B, perhaps by changing protein–protein interactions required for
the replication complex formation. In this scenario, 2K-V9M could
induce more stable or efﬁcient replication complexes than wildtype,
which allow superinfection to occur. Given the data presented, these
complexes, however, would not allow mutant viruses to replicate to
higher titers than wildtype.
Given that 2K V9M enables WNV to replicate in the presence of
the anti-viral agents lycorine and 20, 50 oligoadenylate synthetase
1b (Oas1b) in mammalian cells, some have proposed that struc-
tural changes to ER membranes occur in the presence of V9M that
physically enhance formation of replication complexes (Mertens et
al., 2010; Zou et al., 2009a). This hypothesis was based on the
interpretation that, in the presence of lycorine, 2K-V9M does not
affect viral translation but rather RNA synthesis. In addition, Oas1b
activates RNase L, which then cleaves viral dsRNA replicative
intermediates (reviewed in Silverman, 2007), suggesting that
perhaps V9M prevents degradation of replicative intermediates.
Therefore, an alternative hypothesis for the viral gain of function
mutation imposed by 2K-V9M is that alteration of ER membranes
protects virus replicative intermediates from degradation by host
defense mechanisms, which could increase viral particle packa-
ging and egress without increasing the replication rate per se.
These experiments describe the phenotypic changes associated
with a single amino acid mutation, however, in nature, WNV exists
as a mixture of quasispecies that make up a ﬂuid ﬁtness landscape
(Jerzak et al., 2005). Individual genotypes may rise to dominance
under speciﬁc selective constraints and environmental conditions.
However, a genotype that is advantageous under a speciﬁc set of
environmental conditions may not remain dominant when con-
ditions change. Moreover, the combinatorial effects imposed by
multiple selective pressures to produce a given virus genotype
must be considered. Thus, with 2K-V9M as an individual compo-
nent of the overall viral population, the data presented here are
consistent with the hypothesis that 2K-V9M contributes to ﬁtness
increases compared to wildtype, depending on the coinfection
status of the mosquito.
In summary, our results demonstrate that the 2K-V9M geno-
type was similar to wildtype in replication phenotype in mosqui-
toes, but disseminated more quickly and established secondary
infections more readily than wildtype. Therefore, this point
mutant seems to alter intra- or intercellular transport mechanisms
to evade superinfection exclusion and/or enhance virus dissemi-
nation. However, the evidence that 2K-V9M was unable to out-
compete wildtype in a mixed infection, restricts the conditions in
which it could positively affect virus transmission dynamics in
nature. Moreover it seems likely that, 2K-V9M, arising as part of
the WNV mutant swarm present in a mosquito, could superinfect
previously infected cells, ultimately appearing in the transmitted
pool of WNV, where it can be transmitted to a new host. That this
mutation has not become ﬁxed in the WNV population supports
the observation that its ﬁtness advantage is highly context speciﬁc
and it frequently disappears from the consensus WNV sequence
due to stochastic or selective mechanisms.
Methods
Viruses
Mutant virus infectious clones (ic), wildtype NY99ic and the
marked reference genotype have been described elsewhere
(Fitzpatrick et al., 2010; Shi et al., 2002; Zou et al., 2009b). Virus
infectious clones were reverse transcribed from plasmids using
standard methods (Shi et al., 2002). Virus stocks were prepared by
electroporation of the transcription reactions into baby hamster
kidney cells (BHK-21) (ATCC) maintained in MEM supplemented
with 10% fetal bovine serum at 5% CO2. Passage 0 virus stocks were
used for all experiments described herein. Virus titers were
determined by plaque titration on Vero cells using standard
methods (Lindsey et al., 1976).
Mosquitoes
Colony Cx quinquefasciatus were maintained at 26–27 1C, 60–
70% humidity and a 15:9 (L:D) light cycle. Adult female Cx
quinquefasciatus (5–7 days old) were infected by peroral adminis-
tration of 8 logs plaque-forming units per ml p0 passage mutant,
wildtype (NY99ic), or reference virus stocks diluted into deﬁbri-
nated sheep blood (Colorado Serum Company) and provided to
mosquitoes in a water-jacketed membrane feeder using hog gut.
At indicated times post-infection, mosquitoes were anesthetized
with cold, and carcasses, legs/wings, and salivary expectorants
were collected into cell culture media or in viral RNA extraction
buffer and stored at 80 1C until processing. Following collection
of legs and wings, saliva expectorants were collected by inserting
each mosquito proboscis into an individual capillary pipette
preﬁlled with type B immersion oil (Electron Microscopy
Sciences). After 30 min, the capillary was removed and placed
directly into a collection tube containing cell culture medium or
RNA extraction buffer. After saliva collection, the carcass or midgut
was collected, as well. For the vector competence experiments,
infection rates were determined by calculating the number of
bodies with positive plaque titration results divided by the total
number tested. Dissemination rates were determined by calculat-
ing the number of legs/wings samples with positive plaque
titration results divided by the total number tested. Transmission
rates were determined by calculating the number of bodies with
positive plaque titration results divided by the total number
tested.
Superinfection exclusion
Adult female mosquitoes were fed a primary bloodmeal of
8 logs PFU/ml of the marked reference genome WNV NY99ic.
Engorged females were retained. Egg cups were provided at 2 dpi.
Five days after the primary feed, mosquitoes were fed 8 logs PFU/
ml of a secondary genotype, either wildtype NY99ic or the WNV
2K-V9M point mutant. At 7, 14, 21, and 28 days post-secondary
infection, samples were collected for genotype analysis.
Virus genotyping
Total RNA was extracted from individual mosquito tissues using
the manufacturer's recommendations for the Ambion Viral RNA
extraction kit (Life Technologies) on the Kingﬁsher Flex (Thermo-
Scientiﬁc). RT-PCR ampliﬁcation of a portion of the WNV genome
was used for genotype analysis using methods previously described
(Fitzpatrick et al., 2010). A portion of theWNV genomewas ampliﬁed
by reverse transcriptase PCR (Qiagen) (50 primer- GTGGAA-
GAGGCGGTTGGTGTTACT; 30 primer- TACTTCACTCCTTCTGGCGGTTCA)
and subjected to Sanger sequencing using the primer, GCTCTGC-
CCCTACATGCCGAAAGT. polySNP analysis, which uses PHRED analysis
to read the area under a chromatogram peak, was used to differ-
entiate virus genotypes at positions 8313–8317 (Hall and Little,
2007). The median of all ﬁve marked nucleotide positions was used
to calculate the proportion of mutant genome present. Median values
for each timepoint were entered into Graphpad Prism for statistical
calculations.
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Mixed infection
Viruses were mixed and conﬁrmed to be 56.6%: 43.3% (2K-
V9M: NY99ref) by Sanger sequencing, followed by polySNP ana-
lysis. Cx quinquefasciatus were fed the 2K-V9M / NY99ref mixture
at 8 logs pfu/ml in sheep blood, and tissues were collected at 14
dpi for assessment of viral genotype by polySNP.
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